Silica nanoparticles as hepatotoxicants

被引:190
作者
Nishimori, Hikaru [1 ]
Kondoh, Masuo [1 ]
Isoda, Katsuhiro [1 ]
Tsunoda, Shin-ichi [2 ,3 ]
Tsutsumi, Yasuo [2 ,3 ,4 ]
Yagi, Kiyohito [1 ]
机构
[1] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biofunct Mol Chem, Suita, Osaka 5650871, Japan
[2] Natl Inst Biomed Innovat, Lab Pharmaceut Prote, Osaka, Japan
[3] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan
[4] Osaka Univ, Grad Sch Pharmaceut Sci, Toxicol Lab, Suita, Osaka 5650871, Japan
关键词
Silica particle; Nano-size particle; Liver injury; SCAVENGER RECEPTOR MARCO; ALVEOLAR MACROPHAGES; KUPFFER CELLS; ULTRAFINE PARTICLES; INHALED PARTICLES; BLOOD CLEARANCE; RAT-LIVER; TOXICITY; MICE; BINDING;
D O I
10.1016/j.ejpb.2009.02.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Nano-size materials are increasingly used in cosmetics, diagnosis, imaging and drug delivery, but the toxicity of the nano-size materials has never been fully investigated. Here, we investigated the relationship between particle size and toxicity using silica particles with diameters of 70, 300 and 1000 nm (SP70, SP300, and SP1000) as a model material. To evaluate acute toxicity, we first performed histological analysis of liver, spleen, kidney and lung, by intravenous administration of silica particles. SP70-induced liver injury at 30 mg/kg body weight, while SP300 or 1000 had no effect even at 100 mg/kg. Administration of SP70 dose-dependently increased serum markets of liver injury, serum aminotransferase and inflammatory cytokines. Repeated administration of SP70 twice a week for 4 weeks, even at 10 mg/kg, caused hepatic fibrosis. Taken together, nano-size materials may be hepatotoxic, and these findings will be useful for future development in nanotechnology-based drug delivery system. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:496 / 501
页数:6
相关论文
共 31 条
[1]   Blood clearance rates of adenovirus type 5 in mice [J].
Alemany, R ;
Suzuki, K ;
Curiel, DT .
JOURNAL OF GENERAL VIROLOGY, 2000, 81 :2605-2609
[2]   The scavenger receptor MARCO is required for lung defense against pneumococcal pneumonia and inhaled particles [J].
Arredouani, M ;
Yang, ZP ;
Ning, YY ;
Qin, GZ ;
Soininen, R ;
Tryggvason, K ;
Kobzik, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (02) :267-272
[3]   MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages [J].
Arredouani, MS ;
Palecanda, A ;
Koziel, H ;
Huang, YC ;
Imrich, A ;
Sulahian, TH ;
Ning, YY ;
Yang, ZP ;
Pikkarainen, T ;
Sankala, M ;
Vargas, SO ;
Takeya, M ;
Tryggvason, K ;
Kobzik, L .
JOURNAL OF IMMUNOLOGY, 2005, 175 (09) :6058-6064
[4]  
Bottini M, 2007, INT J NANOMED, V2, P227
[5]  
BRUNNER KT, 1960, J IMMUNOL, V85, P99
[6]   Nanotechnological applications in medicine [J].
Caruthers, Shelton D. ;
Wickline, Samuel A. ;
Lanza, Gregory M. .
CURRENT OPINION IN BIOTECHNOLOGY, 2007, 18 (01) :26-30
[7]   Occupational exposures and autoimmune diseases [J].
Cooper, GS ;
Miller, FW ;
Germolec, DR .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2002, 2 (2-3) :303-313
[8]   BIOLOGICALLY-ACTIVE PRODUCTS OF STIMULATED LIVER MACROPHAGES (KUPFFER CELLS) [J].
DECKER, K .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 192 (02) :245-261
[9]   Cellular target of cyclophosphamide toxicity in the murine liver: Role of glutathione and site of metabolic activation [J].
DeLeve, LD ;
Wang, XD ;
Huybrechts, MM .
HEPATOLOGY, 1996, 24 (04) :830-837
[10]   Silica binding and toxicity in alveolar macrophages [J].
Hamilton, Raymond F., Jr. ;
Thakur, Sheetal A. ;
Holian, Andrij .
FREE RADICAL BIOLOGY AND MEDICINE, 2008, 44 (07) :1246-1258